Fatal Disseminated Strongyloidiasis in a Patient With Untreated HIV: A Diagnostic Challenge. [PDF]
Amdetsion GY +3 more
europepmc +1 more source
Whole Blood Volume-Based Absolute Quantification of HTLV-1 Proviral Load: A Comparative Method Evaluation Study. [PDF]
Franco GO +4 more
europepmc +1 more source
Loss of HTLV-1-specific CD8<sup>+</sup> T-cell immunity in virus carriers predisposed to adult T-cell leukemia/lymphoma. [PDF]
Weterings DA +7 more
europepmc +1 more source
HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL. [PDF]
Ladet J +9 more
europepmc +1 more source
HTLV-1-Infected CD4<sup>+</sup> T Cells Drive Spontaneous Lymphoproliferation and Virus-Specific CD8<sup>+</sup> Cytotoxic T Lymphocyte Expansion in HAM/TSP. [PDF]
Dozono M +8 more
europepmc +1 more source
Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial. [PDF]
Brites C +8 more
europepmc +1 more source
HTLV-I infection among Japanese imigrants living in a rural area in the north of Brazil.
Pontes, Gemilson Soares +10 more
core
Preparation of soluble and functional recombinant HTLV-1 Tax protein using bacterial chaperones. [PDF]
Miura M +5 more
europepmc +1 more source
Related searches:
Human T-cell lymphotropic virus type I (HTLV-I) is known as the causative agent for adult T-cell leukemia (ATL). This same virus was found to be related to another human disease, a progressive spastic paraparesis, found independently in two areas of the world, the Caribbean basin and Japan.
openaire +2 more sources
Sweden is a country with a low prevalence of human lymphotropic T-cell virus (HTLV) infection, estimated at < 0.005%, but the infection rate is notably higher in specific risk groups such as HTLV-2 among intravenous drug users (IVDU) and people originating from HTLV-1 highly endemic areas.
Jan, Vesterbacka +2 more
openaire +2 more sources

